BlackRock Grtr Eur Portfolio Update
29 June 2022 - 2:41AM
UK Regulatory
TIDMBRGE
The information contained in this release was correct as at 31 May 2022.
Information on the Company's up to date net asset values can be found on the
London Stock Exchange website at:
https://www.londonstockexchange.com/exchange/news/market-news/
market-news-home.html.
BLACKROCK GREATER EUROPE INVESTMENT TRUST PLC (LEI - 5493003R8FJ6I76ZUW55)
All information is at 31 May 2022 and unaudited.
Performance at month end with net income reinvested
One Three One Three Launch
Month Months Year Years (20 Sep 04)
Net asset value (Undiluted) -4.1% -7.5% -15.5% 39.8% 576.2%
Share price -7.9% -13.6% -23.1% 37.2% 536.2%
FTSE World Europe ex UK 0.2% 0.5% -1.5% 27.2% 338.1%
Sources: BlackRock and Datastream
At month end
Net asset value (capital only): 492.28p
Net asset value (including income): 497.52p
Share price: 463.00p
Discount to NAV (including income): 6.9%
Net gearing: 0.7%
Net yield1: 1.4%
Total assets (including income): £509.0m
Ordinary shares in issue2: 102,300,411
Ongoing charges3: 1.02%
1 Based on a final dividend of 4.55p per share for the year ended 31 August
2021 and an interim dividend of 1.75p per share for the year ending 31 August
2022.
2 Excluding 15,628,527 shares held in treasury.
3 Calculated as a percentage of average net assets and using expenses,
excluding interest costs, after relief for taxation, for the year ended 31
August 2021.
Sector Analysis Total Assets Country Analysis Total Assets
(%) (%)
Industrials 22.7 Switzerland 19.9
Health Care 22.6 Denmark 19.8
Technology 17.2 Netherlands 16.6
Consumer Discretionary 16.9 France 13.8
Financials 11.7 Sweden 7.0
Consumer Staples 6.0 United Kingdom 6.7
Basic Materials 3.1 Italy 5.8
Net Current Liabilities -0.2 Belgium 2.6
----- Spain 2.5
100.0 Greece 1.8
===== Ireland 1.4
Germany 1.2
Poland 1.1
Net Current Liabilities -0.2
-----
100.0
=====
Top 10 holdings Country Fund%
Novo Nordisk Denmark 8.4
ASML Netherlands 7.5
LVMH Moët Hennessy France 6.0
Lonza Group Switzerland 5.9
RELX United Kingdom 5.6
DSV Panalpina Denmark 4.7
Sika Switzerland 4.4
Royal Unibrew Denmark 3.8
IMCD Netherlands 3.1
Hermès International France 2.8
Commenting on the markets, Stefan Gries, representing the Investment Manager
noted:
During the month, the Company's NAV fell by 4.1% and the share price by 7.9%.
For reference, the FTSE World Europe ex UK Index returned 0.2% during the
period.
European ex UK equity markets continued to experience volatility during May.
Assets associated with the value style outperformed growth assets as markets
tried to factor in the impact higher rates might have on economic growth.
As most market commentators worry about an economic slowdown, we see a very
narrow market with defensives and commodities performing well, whilst most
other sectors struggled. During May, energy, telecommunications and financials
led the market while consumer sectors, health care and industrials were down in
absolute terms. On the positive side, consumer and corporate balance sheets
remain healthy and the Q1 corporate earnings season has shown the majority of
companies in our portfolio continue to post robust results with a confident
outlook for at least the immediate future. Industries that are experiencing
accelerated demand as a result of the current crisis include spending on energy
efficiency, renewables, infrastructure and defence.
We continue to be in an environment where shares are being derated in
anticipation of earnings downgrades. While we are not seeing downgrades
materialising for the majority of companies in the portfolio right now, we have
to acknowledge that the level of uncertainty in markets remains elevated, as we
are far from getting to the end of this period of heightened inflation and
potential economic slowdown. We tend to believe that in periods of slower
growth, companies exposed to structural growth end markets, whose earnings may
slow but not go negative, should ultimately be able to outperform cyclical
areas of the market. These are the types of companies held in the portfolio.
Overall, we retain our core exposure to companies with predictable business
models, higher than average returns on capital, strong cash flow conversions
and opportunities to reinvest that cash flow into future growth projects at
high incremental returns.
The Company underperformed its reference index during the month with both
sector allocation and stock selection being negative. In sector terms, the
Company's lower allocation to energy was negative for performance as the sector
was the standout market leader in May. Given our preference towards owning
quality businesses with high levels of cash flow visibility, resilience and
pricing power, we have been underweight the sector and typically took exposure
to energy only selectively in our Developing European assets. In our view,
companies operating in the space are often reliant on unpredictable underlying
commodity prices, tend to have a poor track record of capital allocation and
can be challenged by the disruption from carbon transition and the need to
re-invest in lower returning renewables projects.
The higher exposure to industrials and technology also detracted, as higher
multiple stocks were once again sold. A negative impact from the portfolio's
overweight to health care was more than offset by accurate stock selection.
The industrials sector was the largest detractor to relative returns during
May. Whilst the stocks we own within the sector are unique in their set up and
often unrelated to each other, most of them suffered from being higher multiple
stocks. Sika, Kingspan and IMCD were amongst the largest detractors. Whilst we
do not believe there are any issues from a fundamental perspective with these
companies, and in fact many of these have reported strong earnings results in
recent months, we acknowledge the risk of a continued derating of higher
quality stocks on the back of concerns over an economic slowdown and hedge
funds cutting exposures.
The Company's position in Novo Nordisk weighed on portfolio returns. There was
one piece of newsflow concerning pricing of a competitor drug, which was
largely in line with our expectations. Operationally, the company is
progressing very well having positively pre-released Q1 results and raised
guidance in April. We continue to see this as a best in class, value creating
and resilient business. The portfolio also suffered by not owning TotalEnergies
- a large index constituent in the energy sector.
On a positive note, the share price pressure on Straumann abated this month -
aiding relative returns. The company announced a small acquisition which will
expand their clear aligners footprint in select European markets and the CEO
confirmed that they are not seeing any evidence of consumer weakness. Aside
from these points, the company also released a very strong update at the end of
April. While the market ignored the update on the day, shares eventually moved
higher over the course of May. There had been some concern around the more
discretionary nature of their dental aligners business in light of consumers
pressured by inflation. However, overall sales grew by 27.2%, a big beat
compared to the consensus estimate of 15.7%.
Lastly, some of the index's large cap defensives sold off during the risk-on
bounce later in the month. Not holding Roche, Nestle, L'Oreal and Richemont was
positive in this context.
At the end of the period, the Company had a higher allocation than the
reference index towards technology, consumer discretionary, industrials and
health care. The Company had an underweight allocation to financials,
utilities, energy, consumer staples, telecoms, real estate and basic materials.
Outlook
So far 2022 has been challenging, with concerns over the economic implications
of the Russia invasion of Ukraine, rising interest rates and continued supply
chain disruptions weighing on equity returns.
While we believe the environment remains supportive for corporate profits
overall, there is potential for a slowdown as growth begins to normalise during
the latter half of the year. Meanwhile the operating environment for companies
continues to be complicated by supply chain and labour market disruptions. In
addition, we expect some of the strong cyclical tailwinds, and indeed policy
support seen in 2021, to fade over the course of 2022. Whilst rate markets and
inflation expectations are likely to stay volatile, we do not expect policy in
Europe to change significantly.
We continue to stay close to our companies which allows us to understand the
environment they are operating in. We expect greater dispersion between sector
and stock outcomes and with that a need for greater selectivity. In our view
this will favour well-managed, well-organised businesses with an element of
pricing power and we believe that holding these businesses will benefit our
shareholders over the medium to long term.
28 June 2022
ENDS
Latest information is available by typing www.blackrock.com/uk/brge on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
END
(END) Dow Jones Newswires
June 28, 2022 12:41 ET (16:41 GMT)
Blackrock Greater Europe... (LSE:BRGE)
Historical Stock Chart
From Apr 2024 to May 2024
Blackrock Greater Europe... (LSE:BRGE)
Historical Stock Chart
From May 2023 to May 2024